USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS TO PREVENT PRIMARY CYTOMEGALOVIRUS (CMV) INFECTION IN PATIENTS WITH ACUTE LEUKAEMIA
Authors:
- 1 October 1988
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 70 (2) , 253-254
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- APPARENT REMOVAL OF GRAFT‐VERSUS‐LEUKAEMIA EFFECT BY THE USE OF LEUCOCYTE‐POOR BLOOD COMPONENTS IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKAEMIABritish Journal of Haematology, 1989
- Cytomegalovirus‐seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banksTransfusion, 1987
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Use of leucocyte‐poor blood components and HLA‐matched‐platelet donors to prevent HLA alloimmunizationBritish Journal of Haematology, 1986